organophosphonates has been researched along with Colorectal Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gajek, G; Kontek, R; Lewkowski, J; Matusiak, A; Morawska, M; Nowak, K; Rzeszotarska, E | 1 |
| Abbattista, MR; Ackerley, DF; Anderson, RF; Ashoorzadeh, A; Bull, MR; Copp, JN; Flanagan, JU; Guise, CP; Mowday, AM; Patterson, AV; Silva, S; Smaill, JB; Williams, EM | 1 |
| Burch, PA; Kovach, JS; Marschke, RF; O'Connell, MJ; Rubin, J; Schutt, AJ; Wieand, HS | 1 |
| Brown, TD; Craig, JB; Einstein, AB; Fleming, T; Goodman, PJ; Macdonald, JS | 1 |
| Berger, MR; Galeano, A; Keppler, BK | 1 |
| Comis, RL; Hudes, GR; O'Dwyer, PJ; Ozols, RF; Paul, AR; Walczak, J | 1 |
| Depisch, D; Haider, K; Kornek, G; Scheithauer, W | 1 |
3 trial(s) available for organophosphonates and Colorectal Neoplasms
| Article | Year |
|---|---|
Advanced colorectal adenocarcinoma: treatment with amonafide.
Topics: Adenine; Antineoplastic Agents; Carcinoma; Colorectal Neoplasms; Humans; Imides; Intercalating Agents; Isoquinolines; Naphthalimides; Organophosphonates | 1994 |
Phase II trial of amonafide in advanced colorectal cancer: a SouthWest Oncology Group study.
Topics: Adenine; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Colorectal Neoplasms; Female; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Organophosphonates | 1993 |
Phase II study of amonafide (nafidamide, NSC 308847) in advanced colorectal cancer.
Topics: Adenine; Adenocarcinoma; Antineoplastic Agents; Colorectal Neoplasms; Drug Evaluation; Humans; Imides; Isoquinolines; Middle Aged; Naphthalimides; Organophosphonates | 1991 |
4 other study(ies) available for organophosphonates and Colorectal Neoplasms
| Article | Year |
|---|---|
Cytotoxic Action of N-aryl, Furan-derived Aminophosphonates against HT29 and HCT116 Cancer Cell Lines.
Topics: Antineoplastic Agents; Apoptosis; Colorectal Neoplasms; Drug Screening Assays, Antitumor; Furans; HCT116 Cells; HT29 Cells; Humans; Membrane Lipids; Organophosphonates; Phosphatidylserines | 2019 |
Rational design of an AKR1C3-resistant analog of PR-104 for enzyme-prodrug therapy.
Topics: 3-Hydroxysteroid Dehydrogenases; Activation, Metabolic; Aldo-Keto Reductase Family 1 Member C3; Animals; Antineoplastic Agents, Alkylating; Benzamides; Carcinoma; Cell Proliferation; Colorectal Neoplasms; Drug Design; Drug Resistance, Neoplasm; Enzyme Inhibitors; Escherichia coli Proteins; HCT116 Cells; Humans; Hydroxyprostaglandin Dehydrogenases; Mesylates; Mice, Nude; Models, Molecular; Molecular Docking Simulation; Nitroreductases; Organophosphonates; Prodrugs; Random Allocation; Recombinant Proteins; Specific Pathogen-Free Organisms; Substrate Specificity; Survival Analysis; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Activity of two platinum-linked phosphonic acids against autochthonous rat colorectal cancer as well as in two human colon-cancer cell lines.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; Colorectal Neoplasms; Drug Screening Assays, Antitumor; Humans; Male; Organophosphonates; Organophosphorus Compounds; Organoplatinum Compounds; Rats; Rats, Inbred Lew; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1992 |
Amonafide in metastatic colorectal carcinoma.
Topics: Adenine; Aged; Antineoplastic Agents; Colorectal Neoplasms; Female; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Neoplasm Metastasis; Organophosphonates | 1990 |